Co-Val s Forte 160 mg/25 mg film-coated tablets
Spain
Table of Contents
Package leaflet: Information for the user
Introduction
Package leaflet: information for the user
Co-Vals Forte 160mg/25mg film-coated tablets
Valsartan/hydrochlorothiazide
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only and must not be given to other people, even if they have the same symptoms as you. It may harm them.
- If you experience any adverse reactions, consult your doctor or pharmacist, even if they are adverse reactions not listed in this leaflet. See section 4.
Leaflet contents
- What Co-Vals Forte is and what it is used for
- What you need to know before taking Co-Vals Forte
- How to take Co-Vals Forte
- Possible side effects
- How to store Co-Vals Forte
- Contents of the pack and other information
1. What Co-Vals Forte is and what it is used for
Co-Vals Forte film-coated tablets contain two active substances known as valsartan and hydrochlorothiazide. These components help control high blood pressure (hypertension).
- Valsartan belongs to a class of medicines known as “angiotensin II receptor antagonists” that help control high blood pressure. Angiotensin II is a substance in the body that causes blood vessels to narrow, resulting in increased blood pressure. Valsartan works by blocking the effect of angiotensin II. As a result, blood vessels relax and blood pressure decreases.
- Hydrochlorothiazide belongs to a class of medicines known as thiazide diuretics. Hydrochlorothiazide increases urine production, which also lowers blood pressure.
Co-Vals Forte is used to treat high blood pressure that is not adequately controlled with a single active component alone.
Hypertension increases the workload on the heart and arteries. If left untreated, it can damage blood vessels in the brain, heart, and kidneys, leading to stroke, heart failure, or kidney failure. High blood pressure also increases the risk of heart attacks. Lowering blood pressure to normal levels reduces the risk of developing these complications.
2. What you need to know before taking Co-Vals Forte
Do not take Co-Vals Forte
-
if you are allergic (hypersensitive) to valsartan, hydrochlorothiazide, sulphonamide-derived substances (chemically related to hydrochlorothiazide), or to any of the other ingredients of this medicine (listed in section 6).
-
if you are more than 3 months pregnant (in any case, it is better to avoid taking this medicine also during early pregnancy – see Pregnancy section).
-
if you have severe liver disease, destruction of small bile ducts in the liver (biliary cirrhosis) leading to bile accumulation in the liver (cholestasis).
-
if you have severe kidney disease.
-
if you are unable to produce urine (anuria).
-
if you are undergoing dialysis.
-
if you have abnormally low levels of potassium or sodium in your blood, or if your blood calcium levels are higher than normal despite treatment.
-
if you have gout.
-
if you have diabetes or renal insufficiency and are being treated with a blood pressure-lowering medicine containing aliskiren.
If any of these situations apply to you, inform your doctor and do not take Co-Vals Forte.
Warnings and precautions
Talk to your doctor before taking Co-Vals Forte
- if you are taking potassium-sparing medicines, potassium supplements, salt substitutes containing potassium, or other medicines that increase blood potassium levels, such as heparin. Your doctor may consider it necessary to monitor your potassium levels regularly.
- if you have low levels of potassium in your blood.
- if you experience severe diarrhoea or vomiting.
- if you are taking high doses of a diuretic.
- if you have severe heart disease.
- if you have heart failure or have had a heart attack. Follow your doctor’s instructions carefully when starting treatment. Your doctor may also monitor your kidney function.
- if you have narrowing of the artery to the kidney.
- if you have recently undergone a kidney transplant.
- if you have hyperaldosteronism, a condition in which the adrenal glands produce too much aldosterone hormone. In this case, Co-Vals Forte is not recommended.
- if you have kidney or liver disease.
- if you have previously experienced swelling of the tongue and face due to an allergic reaction called angioedema while taking other medicines (including ACE inhibitors), inform your doctor. If you develop these symptoms while taking Co-Vals Forte, stop treatment immediately and never take it again. See also section 4 “Possible side effects”.
- if you develop abdominal pain, nausea, vomiting, or diarrhoea after taking Co-Vals Forte. Your doctor will decide whether to continue treatment. Do not stop taking Co-Vals Forte on your own.
- if you develop fever, skin rash, and joint pain, which may be signs of systemic lupus erythematosus (a known autoimmune disease).
- if you have diabetes, gout, or high cholesterol or triglyceride levels in your blood.
- if you have previously had an allergic reaction to another medicine of this class used to lower blood pressure (angiotensin II receptor antagonists), or if you suffer from any type of allergy or asthma.
- if you experience a decrease in vision or eye pain, which could be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or increased eye pressure, occurring within hours to one week after taking Co-Vals Forte. If left untreated, this may lead to permanent vision loss. Your risk may be higher if you have previously been allergic to penicillin or sulphonamides.
- if you are taking any of the following medicines used to treat hypertension (high blood pressure):
- an angiotensin-converting enzyme inhibitor (ACEI) (e.g., enalapril, lisinopril, ramipril), particularly if you have kidney problems related to diabetes.
- aliskiren
- if you have had skin cancer or develop an unexpected skin lesion during treatment. Treatment with hydrochlorothiazide, especially long-term use at high doses, may increase the risk of certain types of non-melanoma skin cancer and lip cancer. Protect your skin from sun and UV exposure while taking Co-Vals Forte.
- if you have previously had breathing or lung problems (such as inflammation or fluid in the lungs) after taking hydrochlorothiazide. If you develop dyspnoea or severe difficulty breathing after taking Co-Vals Forte, seek medical attention immediately.
Your doctor may monitor your kidney function, blood pressure, and levels of electrolytes (e.g., potassium) in your blood at regular intervals.
See also the information under the heading “Do not take Co-Vals Forte”.
Co-Vals Forte may cause increased skin sensitivity to sunlight.
Use of Co-Vals Forte is not recommended in children and adolescents (under 18 years of age).
If you are pregnant, suspect you may be pregnant, or plan to become pregnant, you must inform your doctor. Use of Co-Vals Forte is not recommended during early pregnancy (first 3 months) and must not be used from the third month of pregnancy onwards, as it may cause serious harm to your baby; see Pregnancy section.
Taking Co-Vals Forte with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.
The effect of treatment with Co-Vals Forte may be altered if taken together with certain medicines. Your doctor may need to adjust your dose and/or take other precautions or, in some cases, discontinue treatment with one of the medicines. This is especially relevant for the following medicines:
- lithium, a medicine used to treat certain psychiatric disorders
- medicines or substances that may increase blood potassium levels. These include potassium supplements or potassium-containing salt substitutes, potassium-sparing medicines, and heparin
- medicines that may decrease blood potassium levels, such as diuretics (medicines to increase urine production), corticosteroids, laxatives, carbenoxolone, amphotericin, or penicillin G
- certain antibiotics (from the rifampicin group), a drug used to prevent transplant rejection (cyclosporine), or an antiretroviral drug used to treat HIV/AIDS infection (ritonavir). These drugs may increase the effect of Co-Vals Forte
- medicines that may induce “torsades de pointes” (irregular heartbeats), such as antiarrhythmics (medicines used to treat heart problems) and certain antipsychotics
- medicines that may reduce blood sodium levels, such as antidepressants, antipsychotics, antiepileptics
- medicines used to treat gout, such as allopurinol, probenecid, sulfinpyrazone
- therapeutic vitamin D and calcium supplements
- medicines for treating diabetes (insulin or oral antidiabetics such as metformin)
- other blood pressure-lowering medicines including methyldopa, ACE inhibitors (such as enalapril, lisinopril, etc.), or aliskiren (see also information under the headings “Do not take Co-Vals Forte” and “Warnings and precautions”)
- medicines that increase blood pressure, such as noradrenaline or adrenaline
- digoxin or other digitalis glycosides (medicines used to treat heart problems)
- medicines that may increase blood sugar levels, such as diazoxide or beta-blockers
- cytotoxic medicines (used to treat cancer), such as methotrexate or cyclophosphamide
- pain medicines such as non-steroidal anti-inflammatory drugs (NSAIDs), including selective cyclooxygenase-2 inhibitors (COX-2 inhibitors) and acetylsalicylic acid at doses above 3 g
- muscle relaxants such as tubocurarine
- anticholinergic medicines (used to treat a variety of disorders such as gastrointestinal cramps, urinary bladder spasms, asthma, motion sickness, muscle spasms, Parkinson’s disease, and as an aid in anaesthesia)
- amantadine (a medicine used to treat Parkinson’s disease and also to treat or prevent certain viral diseases)
- cholestyramine and colestipol (medicines mainly used to treat high blood lipid levels)
- cyclosporine, a medicine used to prevent rejection of transplanted organs
- alcohol, sleeping medicines, and anaesthetics (medicines with sedative or pain-relieving effects, used, for example, during surgery)
- iodinated contrast media (used in diagnostic imaging procedures)
Taking Co-Vals Forte with food, drinks, and alcohol
Avoid drinking alcohol until you have discussed it with your doctor. Alcohol may further lower your blood pressure and/or increase the likelihood of dizziness and weakness.
Pregnancy and breastfeeding
-
Inform your doctor if you are pregnant, suspect you may be pregnant, or plan to become pregnant. In general, your doctor will advise you to stop taking Co-Vals Forte before becoming pregnant or as soon as pregnancy is confirmed, and will recommend an alternative antihypertensive medicine. Use of Co-Vals Forte is not recommended during early pregnancy and must not be used from the third month of pregnancy onwards, as it may cause serious harm to your baby when used from that time.
-
Inform your doctor if you are planning to breastfeed or are currently breastfeeding, as Co-Vals Forte is not recommended for women during this period. Your doctor may choose a treatment more suitable if you wish to breastfeed, especially if your baby is a newborn or premature.
Driving and using machines
Before driving a vehicle, using tools, operating machinery, or engaging in other activities requiring concentration, make sure you are aware of how Co-Vals Forte affects you. Like many other medicines used to treat high blood pressure, Co-Vals Forte may rarely cause dizziness and affect your ability to concentrate.
3. How to take Co-Vals Forte
Always take this medicine exactly as your doctor has instructed. This will help you achieve the best results and reduce the risk of adverse effects. If in doubt, consult your doctor or pharmacist again.
People with high blood pressure often do not experience any symptoms and may feel perfectly normal. This makes it very important to keep your appointments with your doctor, even if you feel well.
Your doctor will tell you exactly how many Co-Vals Forte tablets you should take. Depending on how you respond to treatment, your doctor may suggest increasing or decreasing the dose.
- The recommended dose of Co-Vals Forte is one tablet daily.
- Do not change the dose or stop treatment without consulting your doctor.
- This medicine should be taken at the same time every day, usually in the morning.
- You may take Co-Vals Forte with or without food.
- Swallow the tablet with a glass of water.
If you take more Co-Vals Forte than you should
If you experience severe dizziness and/or fainting, lie down and contact your doctor immediately.
If you have accidentally taken too many tablets, contact your doctor, pharmacist, or hospital. You may also contact the toxicology information service at phone number 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Co-Vals Forte
If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose.
Do not take a double dose to make up for forgotten doses.
If you stop taking Co-Vals Forte
If you stop treatment with Co-Vals Forte, your hypertension may worsen. Do not stop taking the medicine unless instructed by your doctor.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible adverse effects
Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.
Some adverse effects may be serious and require immediate medical attention:
-
You should see your doctor immediately if you notice symptoms of angioedema, such as:
-
swelling of the face, tongue or pharynx
-
difficulty swallowing
-
hives and difficulty breathing.
-
Serious skin disease causing skin rash, redness of the skin, blisters on the lips, eyes or mouth, skin peeling, fever (toxic skin necrolysis)
-
Decreased vision or eye pain due to elevated pressure [possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma]
-
Fever, sore throat, increased frequency of infections (agranulocytosis)
These adverse effects are very rare or of unknown frequency.
If you experience any of these symptoms, stop taking Co-Vals Forte and contact your doctor immediately (see also section 2 “Warnings and precautions”).
Other adverse effects include:
Uncommon (may affect up to 1 in 100 people):
- cough
- low blood pressure
- dizziness
- dehydration (with symptoms of thirst, dry mouth and tongue, reduced frequency of urination, dark-coloured urine, dry skin)
- muscle pain
- fatigue
- tingling or numbness
- blurred vision
- noises (e.g. ringing or buzzing) in the ears
Very rare (may affect less than 1 in 10,000 people):
- dizziness
- diarrhoea
- joint pain
Frequency not known (cannot be estimated from available data):
- difficulty breathing
- severe reduction in urine output
- low sodium levels in the blood (which, in severe cases, may cause fatigue, confusion, muscle fasciculations and/or seizures)
- low potassium levels in the blood (sometimes with muscle weakness, muscle cramps, irregular heartbeat)
- low white blood cell count (with symptoms such as fever, skin infections, sore throat or mouth ulcers due to infections, weakness)
- increased bilirubin levels in blood (which, in severe cases, may cause yellowing of the skin and eyes)
- increased blood urea nitrogen and creatinine levels (which may indicate abnormal kidney function)
- increased uric acid levels in blood (which, in severe cases, may trigger a gout attack)
- syncope (fainting)
The following adverse effects have been observed with medicines containing valsartan or hydrochlorothiazide separately:
Valsartan
Uncommon (may affect up to 1 in 100 people)
- sensation of spinning
- abdominal pain
Very rare (may affect less than 1 in 10,000 people):
- intestinal angioedema: swelling in the intestine presenting with symptoms such as abdominal pain, nausea, vomiting and diarrhoea
Frequency not known (cannot be estimated from available data):
- blisters on the skin (sign of bullous dermatitis)
- skin rash with or without itching together with one or more of the following signs or symptoms: fever, joint pain, muscle pain, swollen lymph nodes and/or flu-like symptoms
- skin rash, red-purple spots, fever, itching (symptoms of inflammation of blood vessels)
- low platelet count (sometimes with bleeding or bruising more frequently than usual)
- high potassium levels in blood (sometimes with muscle cramps, irregular heartbeat)
- allergic reactions (with symptoms such as skin rash, itching, hives, difficulty breathing or swallowing, dizziness)
- swelling mainly of the face and throat; skin rash; itching
- increased liver function test values
- decreased hemoglobin levels and reduced percentage of red blood cells in blood (which, in severe cases, may lead to anemia)
- renal failure
- low sodium levels in blood (which, in severe cases, may cause fatigue, confusion, muscle fasciculations and/or seizures)
Hydrochlorothiazide
Very common (may affect more than 1 in 10 people):
- low potassium levels in blood
- increased blood lipids
Common (may affect up to 1 in 10 people):
- low sodium levels in blood
- low magnesium levels in blood
- high uric acid levels in blood
- itchy rash and other types of skin rash
- decreased appetite
- mild vomiting and nausea
- dizziness, dizziness upon standing
- inability to achieve or maintain an erection
Rare (may affect up to 1 in 1,000 people):
- swelling and blisters on the skin (due to increased sensitivity to sunlight)
- high calcium levels in blood
- high blood sugar levels
- sugar in urine
- worsening of diabetic metabolic state
- constipation, diarrhoea, stomach or intestinal discomfort, liver disorders that may occur together with yellowing of the skin and eyes
- irregular heartbeat
- headache
- sleep disturbances
- sadness (depression)
- low platelet count (sometimes with bleeding or bruising under the skin)
- dizziness
- tingling or numbness
- vision disturbances
Very rare (may affect less than 1 in 10,000 people):
-
inflammation of blood vessels with symptoms such as skin rash, red-purple spots, fever (vasculitis)
-
rash, itching, hives, difficulty breathing or swallowing, dizziness (hypersensitivity reactions)
-
facial rash, joint pain, muscle disorders, fever (lupus erythematosus)
-
severe pain in the upper abdomen (pancreatitis)
-
acute breathing difficulty (signs include severe shortness of breath, fever, weakness and confusion)
-
difficulty breathing with fever, cough, wheezing, shortness of breath (breathing difficulty including pneumonitis and pulmonary edema)
-
pale skin, fatigue, shortness of breath, dark-coloured urine (hemolytic anemia)
-
fever, sore throat or mouth ulcers due to infections (leukopenia)
-
confusion, fatigue, muscle twitching and cramps, rapid breathing (hypochloremic alkalosis)
Frequency not known (cannot be estimated from available data):
- skin and lip cancer (non-melanoma skin cancer)
- weakness, bruising and frequent infections (aplastic anemia)
- marked decrease in urine production (possible signs of kidney impairment or kidney failure)
- skin rash, redness of the skin, blisters on the lips, eyes or mouth, skin peeling, fever (possible signs of erythema multiforme)
- muscle cramps
- fever (pyrexia)
- weakness (asthenia)
Reporting of adverse effects:
If you experience any adverse effect, talk to your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly via the Spanish Pharmacovigilance System for Human Medicinal Products: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.
5. Storage of Co-Vals Forte
- Keep out of the sight and reach of children.
- Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month indicated.
- Do not store above 30°C. Keep in the original packaging to protect from moisture.
- Do not use this medicine if you notice that the packaging is damaged or shows signs of tampering.
- Medicines must not be disposed of via wastewater or household waste. Dispose of unused containers and medicines at the SIGRE Point at your pharmacy. If in doubt, ask your pharmacist how to properly dispose of unused containers and medicines. This will help protect the environment.
6. Contents of the pack and other information
Composition of Co-Vals Forte
- The active substances are valsartan and hydrochlorothiazide. Each tablet contains 160 mg of valsartan and 25 mg of hydrochlorothiazide.
- The other components are: microcrystalline cellulose, crospovidone, anhydrous colloidal silica, magnesium stearate.
- The tablet coating contains: hypromellose, macrogol 4000, talc, red iron oxide (E 172), yellow iron oxide (E 172), black iron oxide (E 172), titanium dioxide (E 171).
Appearance of the product and contents of the pack
-
Co-Vals Forte 160 mg/25 mg coated tablets are oval-shaped, brown in colour, with the imprint "HXH" on one side and "NVR" on the other.
-
The tablets are supplied in blister packs with 28 tablets in calendar packaging.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Esteve Pharmaceuticals, S.A.
Passeig de la Zona Franca, 109
08038 Barcelona
Spain
Manufacturer
TOWA PHARMACEUTICAL EUROPE, S.L.
c/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Date of the most recent revision of this leaflet: December 2024
Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/